{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T03:34:28Z","timestamp":1777347268925,"version":"3.51.4"},"reference-count":22,"publisher":"American Society of Hematology","issue":"4","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2001,8,15]]},"abstract":"<jats:p>X-linked lymphoproliferative disease (XLP), a genetic disorder characterized by immunodeficiency to Epstein-Barr virus (EBV) infection, has been linked to mutations in the SH2D1A gene. To search for the occurrence of SH2D1A mutations in Japan, we performed genetic analysis of the SH2D1A gene in 40 males presenting with severe EBV-associated illnesses, including fulminant infectious mononucleosis, EBV-positive lymphoma, and severe chronic active EBV infection. SH2D1A mutations were detected in 10 of these 40 patients. Five of these 10 cases were sporadic. Patients with SH2D1A mutations displayed severe acute infectious mononucleosis with hyperimmunoglobulin M, hypogammaglobulinemia, and B-cell malignant lymphoma. By contrast, chronic active EBV infection was not associated with SH2D1Amutations. XLP survivors exhibited normal levels of circulating EBV-DNA during convalescence, suggesting that SH2D1A protein is not directly responsible for control of EBV replication. Thus, genetic analysis of the SH2D1A gene is particularly useful in the diagnosis of sporadic cases and carriers of XLP.<\/jats:p>","DOI":"10.1182\/blood.v98.4.1268","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T12:46:47Z","timestamp":1027774007000},"page":"1268-1270","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":42,"title":["SH2D1A mutations in Japanese males with severe Epstein-Barr virus\u2013associated illnesses"],"prefix":"10.1182","volume":"98","author":[{"given":"Ryo","family":"Sumazaki","sequence":"first","affiliation":[{"name":"From the Department of Pediatrics, Institute of Clinical Medicine, University of Tsukuba, Japan; Department of Pediatrics, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Japan; Department of Pediatrics, Ibaraki Children's Hospital, Japan; and Department of Pediatrics, Research Institute for Disease Mechanism and Control, Nagoya University School of Medicine, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Kanegane","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, Institute of Clinical Medicine, University of Tsukuba, Japan; Department of Pediatrics, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Japan; Department of Pediatrics, Ibaraki Children's Hospital, Japan; and Department of Pediatrics, Research Institute for Disease Mechanism and Control, Nagoya University School of Medicine, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maki","family":"Osaki","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, Institute of Clinical Medicine, University of Tsukuba, Japan; Department of Pediatrics, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Japan; Department of Pediatrics, Ibaraki Children's Hospital, Japan; and Department of Pediatrics, Research Institute for Disease Mechanism and Control, Nagoya University School of Medicine, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Fukushima","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, Institute of Clinical Medicine, University of Tsukuba, Japan; Department of Pediatrics, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Japan; Department of Pediatrics, Ibaraki Children's Hospital, Japan; and Department of Pediatrics, Research Institute for Disease Mechanism and Control, Nagoya University School of Medicine, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Tsuchida","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, Institute of Clinical Medicine, University of Tsukuba, Japan; Department of Pediatrics, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Japan; Department of Pediatrics, Ibaraki Children's Hospital, Japan; and Department of Pediatrics, Research Institute for Disease Mechanism and Control, Nagoya University School of Medicine, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyoshi","family":"Matsukura","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, Institute of Clinical Medicine, University of Tsukuba, Japan; Department of Pediatrics, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Japan; Department of Pediatrics, Ibaraki Children's Hospital, Japan; and Department of Pediatrics, Research Institute for Disease Mechanism and Control, Nagoya University School of Medicine, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Shinozaki","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, Institute of Clinical Medicine, University of Tsukuba, Japan; Department of Pediatrics, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Japan; Department of Pediatrics, Ibaraki Children's Hospital, Japan; and Department of Pediatrics, Research Institute for Disease Mechanism and Control, Nagoya University School of Medicine, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kimura","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, Institute of Clinical Medicine, University of Tsukuba, Japan; Department of Pediatrics, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Japan; Department of Pediatrics, Ibaraki Children's Hospital, Japan; and Department of Pediatrics, Research Institute for Disease Mechanism and Control, Nagoya University School of Medicine, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Matsui","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, Institute of Clinical Medicine, University of Tsukuba, Japan; Department of Pediatrics, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Japan; Department of Pediatrics, Ibaraki Children's Hospital, Japan; and Department of Pediatrics, Research Institute for Disease Mechanism and Control, Nagoya University School of Medicine, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Miyawaki","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, Institute of Clinical Medicine, University of Tsukuba, Japan; Department of Pediatrics, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Japan; Department of Pediatrics, Ibaraki Children's Hospital, Japan; and Department of Pediatrics, Research Institute for Disease Mechanism and Control, Nagoya University School of Medicine, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2020021216285531400_B1","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0140-6736(75)92004-8","article-title":"X-linked recessive progressive combined variable immunodeficiency (Duncan's disease).","volume":"1","author":"Purtilo","year":"1975","journal-title":"Lancet."},{"key":"2020021216285531400_B2","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1203\/00006450-199510000-00001","article-title":"X-linked lymphoproliferative disease: twenty-five years after the discovery.","volume":"38","author":"Seemayer","year":"1995","journal-title":"Pediatr Res."},{"key":"2020021216285531400_B3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/2424","article-title":"Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene.","volume":"20","author":"Coffey","year":"1998","journal-title":"Nat Genet."},{"key":"2020021216285531400_B4","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/26683","article-title":"The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM.","volume":"395","author":"Sayos","year":"1998","journal-title":"Nature."},{"key":"2020021216285531400_B5","doi-asserted-by":"crossref","first-page":"13765","DOI":"10.1073\/pnas.95.23.13765","article-title":"Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome.","volume":"95","author":"Nichols","year":"1998","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020021216285531400_B6","first-page":"3118","article-title":"Correlation of mutations of the SH2D1A gene and Epstein-Barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease.","volume":"96","author":"Sumegi","year":"2000","journal-title":"Blood."},{"key":"2020021216285531400_B7","first-page":"530","article-title":"Fatal infectious mononucleosis and virus-associated hemophagocytic syndrome.","volume":"111","author":"Mroczek","year":"1987","journal-title":"Arch Pathol Lab Med."},{"key":"2020021216285531400_B8","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/(SICI)1096-8652(200006)64:2<128::AID-AJH11>3.0.CO;2-#","article-title":"Large deletion of the X-linked lymphoproliferative disease gene detected by fluorescence in situ hybridization.","volume":"64","author":"Honda","year":"2000","journal-title":"Am J Hematol."},{"key":"2020021216285531400_B9","first-page":"29","article-title":"Diagnostic guidelines for hemophagocytic lymphohistiocytosis: the FHL Study Group of the Histiocyte Society.","volume":"18","author":"Henter","year":"1991","journal-title":"Semin Oncol."},{"key":"2020021216285531400_B10","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1182\/blood.V87.4.1446.bloodjournal8741446","article-title":"Epstein-Barr virus (EBV)-carrying and -expressing T-cell lines established from severe chronic active EBV infection.","volume":"87","author":"Imai","year":"1996","journal-title":"Blood."},{"key":"2020021216285531400_B11","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/infdis\/157.3.405","article-title":"The chronic mononucleosis syndrome.","volume":"157","author":"Straus","year":"1988","journal-title":"J Infect Dis."},{"key":"2020021216285531400_B12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1128\/CMR.4.1.129","article-title":"Severe chronic active Epstein-Barr virus infection syndrome.","volume":"4","author":"Okano","year":"1991","journal-title":"Clin Microbiol Rev."},{"key":"2020021216285531400_B13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00062752-200001000-00011","article-title":"Chronic, active Epstein-Barr virus infection.","volume":"7","author":"Maia","year":"2000","journal-title":"Curr Opin Hematol."},{"key":"2020021216285531400_B14","doi-asserted-by":"crossref","first-page":"6981","DOI":"10.4049\/jimmunol.162.12.6981","article-title":"Human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP.","volume":"162","author":"Tangye","year":"1999","journal-title":"J Immunol."},{"key":"2020021216285531400_B15","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s004399900168","article-title":"SH2D1A mutation analysis for diagnosis of XLP in typical and atypical patients.","volume":"105","author":"Yin","year":"1999","journal-title":"Hum Genet."},{"key":"2020021216285531400_B16","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/ng0395-232","article-title":"Effect on splicing of a silent FGFR2 mutation in Crouzon syndrome.","volume":"9","author":"Li","year":"1995","journal-title":"Nat Genet."},{"key":"2020021216285531400_B17","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1093\/hmg\/8.13.2407","article-title":"Epstein-Barr virus-negative boys with non-Hodgkin lymphoma are mutated in the SH2D1A gene, as are patients with X-linked lymphoproliferative disease (XLP).","volume":"8","author":"Brandau","year":"1999","journal-title":"Hum Mol Genet."},{"key":"2020021216285531400_B18","doi-asserted-by":"crossref","first-page":"180","DOI":"10.7326\/0003-4819-101-2-180","article-title":"Delayed onset of infectious mononucleosis associated with acquired agammaglobulinemia and red cell aplasia.","volume":"101","author":"Purtilo","year":"1984","journal-title":"Ann Intern Med."},{"key":"2020021216285531400_B19","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1128\/JCM.37.1.132-136.1999","article-title":"Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay.","volume":"37","author":"Kimura","year":"1999","journal-title":"J Clin Microbiol."},{"key":"2020021216285531400_B20","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.4049\/jimmunol.165.6.2932","article-title":"Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome.","volume":"165","author":"Tangye","year":"2000","journal-title":"J Immunol."},{"key":"2020021216285531400_B21","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1084\/jem.192.3.337","article-title":"X-linked lymphoproliferative disease: 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells.","volume":"192","author":"Parolini","year":"2000","journal-title":"J Exp Med."},{"key":"2020021216285531400_B22","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0952-7915(99)80072-7","article-title":"The abnormal gene in X-linked lymphoproliferative syndrome.","volume":"11","author":"Sullivan","year":"1999","journal-title":"Curr Opin Immunol."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/98\/4\/1268\/1675906\/h8160101268.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/98\/4\/1268\/1675906\/h8160101268.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T20:11:34Z","timestamp":1682280694000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/98\/4\/1268\/107076\/SH2D1A-mutations-in-Japanese-males-with-severe"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8,15]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,8,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.v98.4.1268","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2001,8,15]]}}}